2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
V

2020 ASCO Update on mCRPC: Does LuPSMA Have More Compelling Clinical Activity Than Cabazitaxel?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Vivek Narayan
By 2020 ASCO Virtual Direct™ Highlights FEATURING Vivek Narayan
72 views
August 24, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

23:14
AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintena…

Feat. D. Czel, C. Arn

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
GU
08:54
2020 ASCO Virtual Direct™ Highlights

2020 ASCO HIghlights on Prostate Cancer: Does PSMA-Targeted Imaging …

Feat. V. Narayan
10:10
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Prostate Cancer: Did Relugolix Demonstr…

Feat. V. Narayan
09:48
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mCRPC: Does LuPSMA Have More Compelling Clinical…

Feat. V. Narayan